Location History:
- Gothenburg, SE (1989 - 1997)
- Goteborg, SE (1996 - 1997)
Company Filing History:
2 out of 3 
1 out of 1 
1 out of 1 
Years Active: 1989-1997
Title: Innovations of Bo Svennerholm: Pioneering Peptide Research
Introduction
Bo Svennerholm, an accomplished inventor based in Gothenburg, Sweden, has made significant contributions to the field of biomedical research. Holding an impressive portfolio of seven patents, his work primarily revolves around the development of innovative peptides for medical applications.
Latest Patents
Two of his notable recent patents demonstrate his expertise in addressing pressing health concerns. The first patent involves "Peptides for detecting antibodies to HTLV-2". This innovation provides peptides corresponding to epitopes of HTLV-2 proteins that are immunologically reactive with HTLV-2 specific antibodies. The peptides distinguish between antibodies recognizing HTLV-1 and those recognizing HTLV-2, which is crucial for accurately diagnosing HTLV-2 infections. Furthermore, these peptides can be leveraged in vaccine compositions against HTLV-2, potentially enhancing preventive measures in public health.
The second patent titled "Peptides that block human immunodeficiency virus and methods of use" reveals that short peptides, including the tripeptide glycyl-prolyl-glycine, effectively inhibit HIV infection and syncytia formation between infected and non-infected cells. This research holds promise for therapy in patients with HIV and for preventive strategies against the virus.
Career Highlights
Bo Svennerholm's professional journey includes valuable experiences at companies such as Syntello Vaccine Development and Virovahl. His work in these firms has not only advanced his research but also contributed to the broader field of vaccine and therapeutic development.
Collaborations
Throughout his career, Bo has collaborated with notable figures in the scientific community, including Anders Vahlne and Lars Rymo. These partnerships have proven beneficial, leading to groundbreaking research and innovative developments within the realm of virology and immunology.
Conclusion
In summary, Bo Svennerholm's contributions to peptide research and medical innovation underscore his status as a leading inventor in the scientific community. His patents not only represent significant advancements in diagnostic and therapeutic strategies for HTLV-2 and HIV but also highlight the importance of collaboration in driving innovation within the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.